Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized pancreatic cancer.

Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized pancreatic cancer. Int J Radiat Oncol Biol Phys. 2011 Jun 01; 80(2):476-82.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
CA-19-9 Antigen
Combined Modality Therapy
Deoxycytidine
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Leukopenia
Male
Middle Aged
Nausea
Neutropenia
Pancreatic Neoplasms
Radiotherapy, Conformal
Remission Induction

authors with profiles

Mark Talamonti